{"id":"NCT00324350","sponsor":"University of California, San Francisco","briefTitle":"Intensive Glycemic Control and Skeletal Health Study","officialTitle":"Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial (ACCORD-BONE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2006-05-11","resultsPosted":"2012-10-05","lastUpdate":"2012-10-05"},"enrollment":7287,"design":{"allocation":"RANDOMIZED","model":"FACTORIAL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Atherosclerosis","Cardiovascular Diseases","Hypercholesterolemia","Hypertension","Diabetes Mellitus","Coronary Disease"],"interventions":[{"type":"DRUG","name":"hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.","primaryOutcome":{"measure":"Number of Participants With at Least One Non-vertebral Fracture","timeFrame":"Average follow-up of 3.8 years","effectByArm":[{"arm":"Intensive Glycemic Control","deltaMin":198,"sd":null},{"arm":"Standard Glycemic Control","deltaMin":189,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.678"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":5,"countries":["United States","Canada"]},"refs":{"pmids":["22723583","26305617"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}